Scribe Therapeutics Inc. (NASDAQ:SCTX) IPO
IPO
Priced at US$15.00 a share on Jul 23, 2026.
- Price
- US$15.00 a share
- Shares offered
- 8,580,000 shares of common stock
- Offering size
- US$128.7 million
- Underwriters' option
- Up to 1,287,000 more shares
- Listing
- SCTX on the Nasdaq Global Market
- Underwriters
- Leerink Partners, Goldman Sachs & Co. LLC, Guggenheim Securities, Wells Fargo Securities · In the order on the cover
- Shares delivered
- On or about Jul 27, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 9, 2026 |
| Filed publicly | Jul 2, 2026 |
| Amended twice | Newest Jul 20, 2026 |
| Shares registered with an exchange | Jul 21, 2026 |
| Declared effective by the SEC | Jul 23, 2026 |
| Final prospectus, with the price | Jul 27, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 27, 2026 |
| FWP · Free writing prospectus | Jul 24, 2026 |
| EFFECT · Notice that a registration is effective | Jul 23, 2026 |
| S-1MEF · Registration of more shares for the same offering | Jul 23, 2026 |
| CERT · Exchange's certificate of listing | Jul 22, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 21, 2026 |
| S-1/A · Registration statement, amended | Jul 20, 2026 |
| S-1/A · Registration statement, amended | Jul 10, 2026 |
| S-1 · Registration statement | Jul 2, 2026 |
| DRS/A · Draft registration statement, amended | Jun 12, 2026 |
| DRS/A · Draft registration statement, amended | Mar 6, 2026 |
| DRS · Draft registration statement | Jan 9, 2026 |
From the cover of the final prospectus (424B4) filed Jul 27, 2026